Epilepsi tedavisi için yeni bir sınır, hücresel senesans hedefleme yoluyla.
New frontier for epilepsy treatment through targeting cellular senescence.
DOI: 10.1016/j.pnpbp.2025.111506PMID: 40992534
New frontier for epilepsy treatment through targeting cellular senescence.
DOI: 10.1016/j.pnpbp.2025.111506PMID: 40992534
Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism.
DOI: 10.1016/j.nbd.2025.107115PMID: 40992700
Vitamin D Associated with Exercise Can Be Used as a Promising Tool in Neurodegenerative Disease Protection.
DOI: 10.3390/molecules30183823PMID: 41011716
A Hispanic Female Presenting With the Cultural Syndrome "El Salto" as a Psychosomatic Symptom of Anxiety.
DOI: 10.7759/cureus.92861PMID: 41127723
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease.
DOI: 10.1016/j.parkreldis.2025.108057PMID: 40986940
Correlation of <i>DJ-1</i>, <i>GDF15</i>, and <i>MFGE8</i> Gene Expression with Clinicopathological Findings in Gliomas and Meningiomas.
DOI: 10.3390/ijms26189194PMID: 41009755
Repeat Variants, Biomarkers, and Molecular Signatures in Parkinson's Disease: <i>ATXN2</i>, <i>ATXN3</i>, <i>CACNA1A</i>, <i>PRNP</i>, <i>TBP</i>, <i>C9ORF72</i>, <i>TOMM40</i>, <i>APOE</i>, and <i>POLG</i>-A Swedish Perspective.
DOI: 10.3390/ijms26189213PMID: 41009775
Genetic Variants in Cytokines <i>IL-10</i> and <i>IL-17A</i> Are Associated with the Risk and Severity of Sporadic Parkinson's Disease in Mexican Patients.
DOI: 10.3390/life15091480PMID: 41010422
α-Synuclein seed amplification assay positivity beyond synucleinopathies.
DOI: 10.1016/j.ebiom.2025.105925PMID: 40975928
Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects.
DOI: 10.1016/j.phrs.2025.107960PMID: 40976462
Virtual reality in Parkinson's disease: a systematic review and meta-analysis.
DOI: 10.1590/1980-5764-dn-2024-0257PMID: 40990004
Association of brain-derived neurotrophic factor in blood and cerebrospinal fluid with Parkinson's disease and non-motor symptoms of Parkinson's disease: a systematic review and meta-analysis of 6655 participants.
DOI: 10.3389/fnagi.2025.1620172PMID: 41049535
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.